Central Blood Pressure
Early Detection of Central Blood Pressure and Arterial Stiffness (Pulse Wave Analysis) Can be a Predictor of Gestational Hypertension/Preeclampsia.
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The aim of the study is to check standard screening blood pressure in the arm and central blood pressure, the blood pressure at the heart in pregnant women. The standard brachial pressure is routinely monitored throughout pregnancy, however it is not sensitive enough to distinguish preeclampsia from other types of hypertension or to predict preeclampsia in those at risk. Central aortic pressure monitoring has become a valuable clinical tool and preliminary studies suggest that measuring of central blood pressure may be better predictor of preeclampsia. It is non invasive and doesn't require undressing. It involves using a standard blood pressure cuff placed around the thigh, checking carotid pulse and pressure with an ultrasound and taking measurements of the person neck to torso. With this knowledge it will be a useful screening tool to identify these patients at higher risk and hopefully lead to closer monitoring, earlier treatment and reduced morbidity and mortality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2017
CompletedNovember 29, 2017
November 1, 2017
8 months
January 12, 2017
November 27, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
pulse wave analysis
pulse wave analysis can be a predictor of gestational hypertension/preeclampsia.
1 year
Interventions
SphygmoCor XCEL will be used to measure both standard blood pressure in the arm and central pressure, the blood pressure at the heart.
Eligibility Criteria
Pregnant women \> or equal to 14 year old to 60 years old
You may qualify if:
- ≤20 weeks pregnant
You may not qualify if:
- Multi-pregnancy; Fetal anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Vricella, MD
St. Louis University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 20, 2017
Study Start
November 1, 2016
Primary Completion
July 11, 2017
Study Completion
July 11, 2017
Last Updated
November 29, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share